This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Fondation the Ark. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations by Jean-Manuel Segura
Introduction
Jean-Manuel Segura is a notable inventor based in Vevey, Switzerland. He has made significant contributions to the field of medical science, particularly in the area of viral infections. His work focuses on developing innovative solutions to combat respiratory syncytial virus (RSV) infections.
Latest Patents
Jean-Manuel Segura holds a patent for "Fusion respiratory syncytial virus inhibitors and use thereof." This invention relates to novel peptides that are useful for the prevention and/or treatment of RSV infections. His innovative approach aims to provide effective therapeutic options for those affected by this virus.
Career Highlights
Segura is associated with Fondation the Ark, where he continues to work on groundbreaking research and development projects. His dedication to advancing medical science is evident in his focused efforts to address pressing health challenges.
Collaborations
He collaborates with Dominique Garcin, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Jean-Manuel Segura's work exemplifies the spirit of innovation in the medical field, particularly through his patent aimed at combating RSV infections. His contributions are vital in the ongoing fight against viral diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile